AMICUS THERAPEUTICS INC
NASDAQ: FOLD (Amicus Therapeutics, Inc.)
最近更新时间: 15小时之前9.90
-0.05 (-0.50%)
| 前收盘价格 | 9.95 |
| 收盘价格 | 9.99 |
| 成交量 | 3,386,792 |
| 平均成交量 (3个月) | 5,093,623 |
| 市值 | 3,054,481,920 |
| 预期市盈率 (P/E Forward) | 20.83 |
| 价格/销量 (P/S) | 5.03 |
| 股市价格/股市净资产 (P/B) | 13.10 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业毛利率 | -5.41% |
| 营业利益率 (TTM) | -6.35% |
| 稀释每股收益 (EPS TTM) | -0.090 |
| 季度收入增长率 (YOY) | 13.40% |
| 总债务/股东权益 (D/E MRQ) | 229.11% |
| 流动比率 (MRQ) | 3.34 |
| 营业现金流 (OCF TTM) | 3.56 M |
| 杠杆自由现金流 (LFCF TTM) | 29.27 M |
| 资产报酬率 (ROA TTM) | 3.95% |
| 股东权益报酬率 (ROE TTM) | -18.12% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Amicus Therapeutics, Inc. | 看跌 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 1.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.00 |
|
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 0.72% |
| 机构持股比例 | 103.25% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Avoro Capital Advisors Llc | 30 Sep 2025 | 15,025,000 |
| Vestal Point Capital, Lp | 30 Sep 2025 | 9,750,000 |
| Pictet Asset Management Holding Sa | 30 Sep 2025 | 6,788,164 |
| Perceptive Advisors Llc | 30 Sep 2025 | 6,370,851 |
| Palo Alto Investors Lp | 30 Sep 2025 | 5,367,798 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 19.00 (JP Morgan, 91.92%) | 购买 |
| 中 | 14.00 (41.41%) | |
| 低 | 11.00 (Goldman Sachs, 11.11%) | 保留 |
| 平均值 | 14.67 (48.18%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 8.86 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JP Morgan | 06 Nov 2025 | 19.00 (91.92%) | 购买 | 8.90 |
| Goldman Sachs | 05 Nov 2025 | 11.00 (11.11%) | 保留 | 9.19 |
| Needham | 18 Sep 2025 | 14.00 (41.41%) | 购买 | 8.48 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CAMPBELL BRADLEY L | - | 9.85 | -29,174 | -287,218 |
| CASTELLI JEFF | - | 9.89 | -76,158 | -753,203 |
| CLARK DAVID MICHAEL | - | 9.89 | -25,643 | -253,609 |
| PROUT SAMANTHA | 9.80 | - | 32,193 | 315,491 |
| ROSENBERG ELLEN | - | 9.93 | -95,621 | -948,042 |
| 累积净数量 | -194,403 | |||
| 累积净值 ($) | -1,926,581 | |||
| 累积平均购买 ($) | 9.80 | |||
| 累积平均卖出 ($) | 9.89 | |||
| 内部人员交易波幅 ($) | ||||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| PROUT SAMANTHA | 职员 | 01 Dec 2025 | 获得 (+) | 32,193 | 9.80 | 315,491 |
| CAMPBELL BRADLEY L | 职员 | 01 Dec 2025 | 卖 (-) | 14,587 | 9.80 | 142,953 |
| CAMPBELL BRADLEY L | 职员 | 01 Dec 2025 | 执行期权 | 14,587 | - | - |
| ROSENBERG ELLEN | 职员 | 26 Nov 2025 | 卖 (-) | 23,621 | 10.02 | 236,682 |
| ROSENBERG ELLEN | 职员 | 26 Nov 2025 | 执行期权 | 23,621 | - | - |
| ROSENBERG ELLEN | 职员 | 25 Nov 2025 | 卖 (-) | 36,000 | 9.87 | 355,320 |
| ROSENBERG ELLEN | 职员 | 25 Nov 2025 | 执行期权 | 36,000 | - | - |
| ROSENBERG ELLEN | 职员 | 24 Nov 2025 | 卖 (-) | 36,000 | 9.89 | 356,040 |
| ROSENBERG ELLEN | 职员 | 24 Nov 2025 | 执行期权 | 36,000 | - | - |
| CAMPBELL BRADLEY L | 职员 | 24 Nov 2025 | 卖 (-) | 14,587 | 9.89 | 144,265 |
| CAMPBELL BRADLEY L | 职员 | 24 Nov 2025 | 执行期权 | 14,587 | - | - |
| CLARK DAVID MICHAEL | 职员 | 24 Nov 2025 | 卖 (-) | 25,643 | 9.89 | 253,609 |
| CASTELLI JEFF | 职员 | 24 Nov 2025 | 卖 (-) | 76,158 | 9.89 | 753,203 |
| CASTELLI JEFF | 职员 | 24 Nov 2025 | 执行期权 | 50,000 | - | - |
| 显示更多 | ||||||
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合